HOME › DRUGS › LENACAPAVIR
ACTIVE SUBSTANCE / INN

LENACAPAVIR

Brand name(s): Yeytuo, Sunlenca, YEZTUGO
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA220018
HIV Infections;HIV-1
ACTIVE SUBSTANCE
Lenacapavir
REGULATORS
FDA · EMA
SPONSORS / MAH
GILEAD SCIENCES INC, Gilead Sciences Ireland Unlimited Company
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
YEZTUGONDA220018GILEAD SCIENCES INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
YeytuoGilead Sciences Ireland Unlimited CompanyAuthorised25/08/2025HIV Infections;HIV-1
SunlencaGilead Sciences Ireland Unlimited CompanyAuthorised17/08/2022HIV Infections

FULL INTELLIGENCE ON LENACAPAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →